Work

Human Epidermal Growth Factor Receptor 2 (her2) in Gastric Cancer (gc) (results of the Multicenter Clinical Trial)

Year: 2017

Type: article

Abstract: In this article results of the multicenter trial are displayed. Data of successful efficacy of trastuzumab treatment in HER2 positive gastric cancer patients has shown.

Source: DOAJ (DOAJ: Directory of Open Access Journals)

DOI: 10.24060/2076-3093-2013-0-4-16-22

Authors: H. C. Chung, Y-J. Bang, J. M. Xu, F. Lordick, A. Sawaki, O. Lipatov, M. Lehle, М. Pickl, J. Ruschoff, E. Van Cutsem

Institutions: Yonsei University, Yonsei Cancer Hospital, F. Hoffmann-La Roche AG, Aichi Cancer Center, Republican Oncological Clinical Dispensary, Laboratoire de Biologie Moléculaire des Eucaryotes

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2800403161

FWCI:

Cites:

Cited by:

Related to: 10